English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
American Academy Of Neurology
Sam Jackson
| Apr 25, 2023
Teriflunomide study shows promise in delaying first symptoms of MS using medication as an 'early intervention'
Sam Jackson
| Apr 25, 2023
New drug shows promise in preventing migraines for patients unresponsive to other treatments: 'These results are exciting'
Press release submission
| May 2, 2019
AMERICAN ACADEMY OF NEUROLOGY: Cannabis-based Medicine May Reduce Seizures for Children with Difficult-to-Treat Epilepsy
Robert Hadley
| May 16, 2017
Immunosuppressive drug cladribine may slow progression of MS
Ruth de Jauregui
| May 7, 2017
Data from multiple sclerosis medication study shows promise
Robert Hadley
| May 3, 2017
Clinical trial results offer hope for multiple sclerosis sufferers
Amanda Rupp
| May 22, 2016
New ALS research announced at annual conference
Amanda Rupp
| Apr 21, 2016
ALS Association announces new research fellowships
Trending
+
Regulatory
Patient Daily News Service
| Jan 12, 2025
National Consumers League CEO: Federal 340b drug discount program ‘hijacked by hospitals and contract pharmacies’
+
Regulatory
Patient Daily News Service
| Jan 16, 2025
FTC Chair: Report Finds 'Three Major Pharmacy Benefit Managers Hiked Costs for a Wide Range of Lifesaving Drugs, Including Medications to Treat Heart Disease and Cancer'
+
Regulatory
Patient Daily reports
| Jan 14, 2025
National health reform group: 'Plenty of evidence that hospitals are not passing along' discounted drug prices under 340b program
+
Pharmaceuticals
Patient Daily
| Jan 15, 2025
Dr. Peter Hotez receives 2025 Hill Prize for public health innovations
